Global Stories
Fighting for Survival: The Insulin Crisis in the Democratic Republic of Congo
23 Sep 2025, 8:02 p.m. in Global Stories by T1International
In the Democratic Republic of Congo (DRC), living with type 1 diabetes is not only a daily challenge–it’s a fight for survival. Access to insulin is deeply unequal and increasingly precarious due to conflict, economic instability, and fragile health systems. Two members of the T1International network, Dr. Kalehezo Murhabazi Albert and Professor Justin Cikomola Cirhuza, share a glimpse into what this crisis looks like on the ground. Read more
World Health Organization Approves Rapid-Acting Insulin Analogues to the 24th EML
5 Sep 2025, 2:56 p.m. in Global Stories, News & Statements by T1International
Global Diabetes Advocates Urge Novo Nordisk’s New CEO to Prioritize People Over Profits
7 Aug 2025, 8:27 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
Findings from T1International's 2024 Out-of-Pocket Expenses and Rationing Survey
28 May 2025, 4:15 p.m. in #insulin4all USA, Global Stories by T1International
Progress on Insulin Access: Adding Rapid-Acting Insulin Analogues to the Essential Medicines List
9 Apr 2025, 10:04 p.m. in Global Stories, News & Statements by T1International
T1International Year in Review: 2024
15 Dec 2024, 11:41 a.m. in #insulin4all USA, Global Stories, News & Statements by T1International
As 2024 comes to an end, we’re taking a moment to reflect on the collective power of the T1International community. This year has been filled with challenges and victories as we’ve worked together to fight for affordable and accessible insulin. Here’s a month-by-month look at what we’ve accomplished, thanks to your support and the dedication of advocates across the globe. Read more
Make it Right: The Fight for Insulin Access on World Diabetes Day
20 Nov 2024, 6:19 p.m. in #insulin4all USA, Global Stories by Shaina Kasper
On World Diabetes Day, we shine a spotlight on a glaring injustice: millions of people with diabetes in low- and middle-income countries are denied access to affordable insulin pens—a delivery method that could save and transform lives. Pharmaceutical giants Eli Lilly, Novo Nordisk, and Sanofi have monopolized the diabetes market, prioritizing profit over people. It’s time to demand change. It’s time to make it right. Read more
Facing My Guilt: I am surviving, but diabetics in Gaza are not
19 Aug 2024, 8 p.m. in Global Stories by Ali Hisham
Ten years ago, when I was first diagnosed with type one diabetes, I spent countless hours studying my newly diagnosed condition. I came across a research paper by Stanford University stating that people living with type 1 diabetes make around 180 more decisions per day than people without diabetes, with a rate of an extra decision every 5 minutes of waking time. I then realised that type 1 diabetes is a full-time job, without vacations or time off. Read more
Global Advocacy Success Series: Kelia Moses, WE Care Sierra Leone
24 Jul 2024, 9:22 a.m. in Global Stories by Kelia Moses
The idea to work on this issue stemmed from a personal experience that deeply impacted me. In 2008, I lost my aunt to diabetes-related complications. Witnessing her struggle with diabetes and the lack of medical expertise to detect and manage her condition was a profound and heartbreaking experience for me. Read more
Insulin Shortages: a policy choice with policy solutions
8 May 2024, 4:38 p.m. in #insulin4all USA, Global Stories, Interviews by Shaina Kasper, Policy & Advocacy Director, T1International
Over the past few months, people with type 1 diabetes around the globe have been going from pharmacy to pharmacy in search of insulin. There have been insulin shortages in many different countries. For people living with type 1 diabetes, insulin is as important as oxygen and people need a consistent supply. Insulin shortages can lead to irreversible complications and even death. Read more